AI
KRON

Alphabet Inc’s Kronos Bio KRON Stock Holding History

Alphabet Inc’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,438,232
Closed -$1.19M – 38
2025
Q1 		$1.19M Hold
1,438,232
– – 0.08% 28
2024
Q4 		$1.37M Hold
1,438,232
– – 0.08% 26
2024
Q3 		$1.44M Hold
1,438,232
– – 0.08% 30
2024
Q2 		$1.78M Hold
1,438,232
– – 0.09% 30
2024
Q1 		$1.87M Hold
1,438,232
– – 0.07% 31
2023
Q4 		$1.8M Hold
1,438,232
– – 0.08% 31
2023
Q3 		$1.87M Hold
1,438,232
– – 0.12% 31
2023
Q2 		$2.47M Hold
1,438,232
– – 0.13% 31
2023
Q1 		$2.1M Hold
1,438,232
– – 0.12% 34
2022
Q4 		$2.33M Hold
1,438,232
– – 0.14% 32
2022
Q3 		$4.82M Hold
1,438,232
– – 0.25% 31
2022
Q2 		$5.24M Hold
1,438,232
– – 0.28% 32
2022
Q1 		$10.4M Hold
1,438,232
– – 0.34% 29
2021
Q4 		$19.5M Hold
1,438,232
– – 0.47% 26
2021
Q3 		$30.1M Hold
1,438,232
– – 0.72% 16
2021
Q2 		$34.4M Hold
1,438,232
– – 0.7% 15
2021
Q1 		$42.1M Hold
1,438,232
– – 1.7% 12
2020
Q4 		$43M Buy
+1,438,232
New +$45.1M 2.06% 11

Alphabet Inc's KRON Position: Q2 2025 in Review

Alphabet Inc sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 1,438,232 shares — an estimated $1.19M sold.

Alphabet Inc first reported a position in KRON in Q4 2020 and held it in 18 quarters. The position peaked at $43M in Q4 2020. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.

  • Alphabet Inc reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
  • Alphabet Inc sold 1,438,232 Kronos Bio shares in Q2 2025, an estimated $1.19M.
  • Alphabet Inc first reported a position in Kronos Bio in Q4 2020 and held it in 18 quarters.
  • Alphabet Inc's Kronos Bio position peaked at $43M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.

Based on Alphabet Inc's 13F filing for Q2 2025, filed 1 Aug 2025.